Abstract
IntRoduCtIon
U veal melanoma, the most common primary intraocular malignancies in adults, is usually found in the people who are in their 40's to 50's. The morbidity of the uveal melanoma is around seven millionths and most people are diagnosed as unilateral disease [1] . The uveal melanoma which accounts for 5%-6% of primary melanoma ranks at the second place next to skin melanoma [2] . There are miscellaneous treatments for uveal melanoma, however, these therapies are mainly focused on the local treatment of the eyeball, which does not improve the status of metastatic patients. The uveal melanoma has one prominent feature that no matter what successful local treatment of the tumor in the eye, about 50% of the patients still die from the distant metastasis of the tumor. After the metastasis of the patient, most of the patients die within a few months. The survival period is only 2 to 7mo. Only 13% of the patients survive for more than 1y, and the average survival time is less than 6mo [3] . Uveal melanoma not only seriously threatens the patient's vision, but also seriously intimidates the patient's life. Although in the past nearly 30y, the diagnosis and treatment of uveal melanoma has had significant progress, unfortunately, it not fundamentally solved the key problems of tumor metastasis, the 5-year survival rate of patients with no obvious improvement. The crux of the problem is that for uveal melanoma spreading to the liver, has yet to fully understand, cannot be effective intervention; as early as 1978, Zimmerman et al [4] put forward "The metastasis of uveal melanoma may be an early event, and the metastasis may occur before the tumor is ready to be removed." Therefore, metastasis has become a bottleneck restricting the therapeutic effect of uveal melanoma. The underlying cause of the disease is that there is no understanding of the cause and mechanism of metastasis, therefore early intervention and treatment of uveal melanoma cannot be performed from pathogenesis. In our previous study [5] , the microRNA profiling of uveal melanoma performed by using Agilent microRNA array demonstrated that expressions of many microRNAs were up-regulated and down-regulated significantly compared with normal uveal tissue. MicroRNA-21, a well-known oncogene, found overexpress in multiple cytology types of uveal melanoma tissue. MicroRNA-21, first found highly expressing in malignant glioma [6] , blocks expression of apoptosis-associating key genes. MicroRNA-21 regulates and participates in multiple steps of tumor metastasis [7] , involving in the tumorigenesis of liver cancer, gastrointestinal malignancy, breast cancer, cutaneous melanoma, and other tumors [8] [9] [10] [11] [12] [13] , while mechanisms of microRNA-21 in uveal melanoma were haven't been researched. In this report, the effect of overexpression and inhibition of microRNA-21 on uveal melanoma cell line behavior was evaluated. ) cells were seeded each well into the upper chambers of transwell culture plates, each with an 8-μm pore membrane insert (Corning, Shanghai, China). RPMI-1640 medium supplemented with 10% FBS was placed in the lower chambers as a chemo-attractant. After incubation for 24h, cells that had penetrated through to the lower surface of the membrane were fixed with 4% paraformaldehyde for 20min, stained with crystal violet for 20min at ambient temperature, photographed, and counted under inverted microscope (ShangHai Caikon Optical Instrument Co., Ltd., China) at ×200 and magnification in nine randomly chosen fields. The cell invasion assay was similar to the migration assay except that the transwell chambers were coated with matrigel solution (40 μL per chamber; matrigel:serum-free medium ratio 1:10). OCM-1 ( 1×10 5 ), M619 (80 000) and MuM-2B (80 000) cells were seeded into the upper chambers of the transwells and RPMI-1640 medium with 20% FBS (600 μL) was added to the lower chambers. After 20h incubation, the cells that had penetrated the matrigel and moved to the lower surface of the membrane were fixed with 4% paraformaldehyde and stained with crystal violet. Cells adhering to the upper-surface of the membrane were removed with a cotton swab. The cells attached to the lower surface were counted and photographed under an inverted microscope (ShangHai Caikon Optical Instrument Co., Ltd., China) at ×200 and magnification in nine randomly chosen fields. Vector Construction and dual luciferase Reporter Assay Constructing the microRNA-21 expression vector (pre-hsa-miR-21), two fragments encompassing the mature microRNA-21 sequence and its 5'-and 3'-flanking regions were synthesized chemically and then cloned into the XhoI and EcoRI sites in GV262 (Genechem, Shanghai). The fulllength wild-type 3' untranslated region (UTR) of p53 and mutant 3' UTR of p53 containing predicted miR-21-3p target sites were amplified by PCR from human monocyte total RNA and then cloned into the XhoI and SacI sites of GV126 vector (Genechem, Shanghai). All plasmids were confirmed by DNA sequencing. These plasmid vectors were cotransfected using Lipofectamine 2000 (Invitrogen) respectively into 293T cells. Luciferase was measured 48h after transfection using the DualLuciferase Reporter Assay System (Promega, Madison, WI, USA) according to the manufacturer's instructions. The firefly luciferase activity was then normalized to β-galactosidase activity. Experiments were repeated three times independently. The housekeeping GAPDH was used as the normalization control. The spectrophotometer determined the total protein extracted from each groups of uveal melanoma cells by homogenizing (Figure 2A, 2E, 2I ). According to MTT test results above, the BrdU test was further conducted on Figure 2C , 2G and 2K), probably by blocking OCM-1 cell at G1 phase, MuM-2B cell at S and G2 phase and M619 cell at G2 phase ( Figure 2D , 2H, 2L). In cell migration assay ( Figure 3A ), we observed that cells' ability to metastasize was significantly strengthened (P<0.05) by stable overexpression of microRNA-21 in MuM-2B (P=0.037) and OCM-1 (P=0.035) cell lines, and weaken by stable inhibition of microRNA-21. However, metastatic rate of M619 cell was improved but not showing statistical significant different. In Matrigel invasion assay ( Figure 3B ), results showed that cell invasive abilities of OCM-1, M619 and MuM-2B, these three different uveal melanoma cell lines with different cytological properties, were all significantly strengthened and weaken by stable overexpression and inhibition of microRNA-21. These results suggested that microRNA-21 may be important in the progression of uveal melanoma through enhancing cell invasion and migration that can make highly invasive tumor cells as MuM-2B still been improved by microRNA-21 overexpression. Wild p53, the direct target of hsa-microRnA-21-3p To explore the mechanisms by which miR-21 promote tumor cell proliferation and invasion, we used several computational methods to help identify miR-21 targets in humans. We found that miR-21 has binded in the 3'UTR of p53 ( Figure 4A ). In order to determine whether p53 were a direct target of miRNA-21, we carried out luciferase reporter assays. Dual luciferase assay system was used to test the interaction between miRNA-21 and wild type p53 mRNAs. The luciferase activities of wild type p53 3'UTR are decreased compared with its mutant type by cotransfected with P-microRNA-21 ( Figure 4B Figure 4C ). Protein levels of wild P53 were determined by Western blot in lenti-virus infected uveal melanoma cell lines. The result showed that a clear reduction in the level of endogenous wild p53 protein was observed in micro up group of OCM-1, MuM2B and M619 cell lines, especially in MuM-2B. In contrast, micro down groups reveal darker strips compared with NC-down groups ( Figure 4D ). downstream effective Proteins of p53 In our previous study [14] , protein level of LASP1 and GST-pi had been found overexpression in uveal melanoma tissue sample there for the expectation about LASP1 and GST-pi as downstream proteins of wild p53 to influence the metastasis of uveal melanoma were formed. To determine this idea, effects of microRNA-21 expression on mRNA and protein levels of LASP1 and GST-pi in uveal melanoma cell lines OCM-1, M619 and MuM-2B were been evaluated using qRT-PCR and Western blot on each group of uveal melanoma. Results of RT-PCR showed that LASP1 were up-regulated in micro up groups and down-regulated in micro down groups ( Figure 5A ) as expecting, and showed significantly statistical dif ference. Results of Western blot ( Figure 5B ) supported the mRNA regulating as well. However, GST-pi didn't show the same pattern as we expected. The mRNA express level of GST-pi in OCM-1 cells with overexpression and inhibition of microRNA-21 were upregulated and down-regulated respectively, but showed no significant difference. GST-pi was decreased in microRNA-21 overexpressing MuM-2B, and increased in M619 cells with inhibition of microRNA-21. This result did not match the Western blot results ( Figure 5C, 5D) . 
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Tumor mass of micro down group of OCM-1 cell line were grow slower than NC-down group, and the weight of tumors were lighter as well ( Figure 6 ). dIsCussIon Choosing OCM-1, a spindle cell line with low invasiveness, M619, an in situ epithelial cell line with high invasiveness, and MuM-2B, an invasive epithelial cell lines with high liver metastasis in the experiment, we studied the variations of the cellular functions in the uveal melanoma cell line under a situation with overexpression and inhibition of microRNA-21. Emerging evidences suggest that miRNA-21 promoted proliferation, migration, and invasion of OCM-1, M619, and MuM-2B cells in vitro by targeting p53. Expression of p53 gene would be inhibited when the expression of microRNA-21 increased, and the downstream protein which were LASP-1 and GST-pi would be highly expression. On the other hand, down-regulation of microRNA-21 results in opposite consequence. Furthermore, inhibition of microRNA-21-3p decreased tumor growth in vivo. MicroRNA-21 were found over-expressing in various solid tumor diseases such as lung cancers, breast cancers, glioblastoma, stomach cancers, pancreatic cancers, pancreatic neuroendocrine tumors, liver cancers, bile duct cancers, colon cancers and prostate cancers [15] . Through this study, we learned that microRNA-21 promoted the proliferation and metastases of uveal melanoma cell lines, and functions of the cells were consistent with that in the scientific literatures. In glioma cells, microRNA-21 can play its oncogenic role by acting on sophisticated tumor suppressing signal pathways. This theory was confirmed by various studies indicated that tropomyosin 1 (TPM1) [16] , programmed cell death factor 4 (PDCD4) [17] , phosphatase and tensin homolog deleted on chromosome ten (PTEN) and p53 signal path [18] could be all participating.
Using online target gene predicting softwares to find out that p53 in the target gene of microRNA-21-3p, we verified the binding site of p53 and microRNA-21-3p by the dualluciferase reporter gene detection method. qRT-PCR result shows that mRNA level of p53 in the uveal melanoma cell lines with up-regulated microRNA-21 was down-regulated. This is consistent with the report [19] that microRNA-21 can negatively regulate p53 in tumor cells, demonstrating that microRNA-21 can also be used to inhibit tumor apoptosis and promote proliferation and metastasis by down-regulating p53 expression in uveal melanoma cell lines. The modulating Email:ijopress@163.com mechanisms might be that microRNA-21 performed directly on the 3'UTR of p53 managing the stabilities of p53 to achieve the relevant regulations; furthermore, microRNA-21 regulated p53 by adjusting the upstream genes of p53. p53 is involved in constituting its numerous downstream genes as a promoter which can all be found a conservative binding site on p53 [20] . Through these promoters, p53 regulates transcription of a large amount of downstream genes, including microRNAs. Furthermore, P53 can also be used as a binding protein of RNA, which can indirectly regulate microRNAs by influencing the recruitment and binding process of microRNAs for mRNA. In our previous study [14] , comparative proteomics were designed to exam the pre-stage of metastases in progress of uveal melanoma. Comparing surgical excised uveal melanoma tissues with normal uveal tissue, for the first time we discovered that GST-pi overexpressed in uveal melanoma tissues, and LASP1 only expressed in uveal melanoma tissues not normal uveal tissues. Both proteins are targets of wild-type p53 [21] [22] . GST-pi and LASP1 were associated with tumor invasions and metastases; furthermore, they might be connected with liver metastases. Simultaneously, the expressions of GST-pi were up-regulated in proteomic analyses, which were both found in the uveal melanoma metastatic cell lines and primary cell lines [23] .
LASP1 as an adhesion protein, was found up-regulated in miscellaneous malignancies reported in many studies. It was initially identified from a cDNA library of breast cancer metastases [24] . LASP1, as a dynamic adhesion spot protein [25] , combined directly with the carboxy terminal domain of chemokine receptor CXCR and became a pre-migration modulator that managed malignant tumor cell migration [26] .
According to transwell assays and scratching experiments, LASP1 could enhance cellular invasive and migratory potential. Immunofluorescence technique revealed that LASP1 might interfere cytoskeleton remodeling processes such as actin to alter cell motile potential leading to tumor metastases [27] .
Comparing LASP1 expressions in the cytoplasm and nucleus of the hepatocellular carcinoma with normal liver cells, results showed that the express level of LASP1 in hepatocellular carcinoma was higher than adjacent non-neoplastic tissues. Furthermore, LASP1 expression related to hepatitis B surface antigen (HBsAg) and serum alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma. Highly expressions of LASP1 in cytoplasm should take respond to deteriorating clinical prognoses. Multivariable analysis demonstrated that the intracellular LASP1 express level was an independent prognostic factor to patients' survival rate. LASP1 could encourage cell proliferation and migration, which made cancer cells develop into an aggressive phenotype [28] . Wang et al [29] discovered LASP1 as a transcriptional target of wild type p53, which restrained LASP1 expression. Missense of mutant p53-r175h [29] [30] in the key region of the DNA binding domain destroying the p53-mediated LASP1 expression inhibition revealed that p53 might affect tumor metastases by interfering the mechanism of LASP1. GST-pi is a phase II metabolic enzyme that is important in the detoxification of a wide range of electrophiles through oxidative metabolism to protect tumor cells from cytotoxic drugs [31] [32] . Wang et al [33] found that GST-pi is up-regulated in the metastatic and invasive potential of gastric cancer cells by transforming growth factor-β1 (TGF-β1), which may be involved in TGF-β1-induced enhanced gastric cancer transfer potential. Investigating glutathione S-transferase isoforms within colorectal cancer tissue, normal liver tissues and liver metastasis tumor tissue from the patients with colorectal cancer, Mulder et al [21] learned GST-pi was found to be higher expressed in all liver metastasis tumor tissue than normal liver tissues. GST-pi reveals only in tumor cells and, except for the biliary epithelium and hepatocytes. It indicated colorectal cancer liver metastasis is related to GST-pi expression and activation. GST-pi expression is regulated by the activator protein 1 (AP-1) transcription factor activated by the stress-activated JNK pathway and is involved in the signaling pathway of apoptosis [34] . However, GST-pi interacts with activated JNK1 or JNK2 activates transcription factor 2 (ATF2), which directly inhibits the phosphorylation of ATF2 by activating JNK by binding to ATF2 or JNK and ATF2 complexes, thereby inhibiting apoptosis and causing tumor growth and metastasis [35] . Studies had revealed that GST-pi closely related to the tumor invasion and metastases. Zhang et al [36] reported that GST-pi was found to be up-regulated in colorectal adenocarcinoma with positive expression of tumor suppressor gene p53 mutant protein, indicating that GST-pi expression may be related to p53. Jardim et al [37] also reported the same discoveries in breast cancer tissues and explained that the higher expressions of GST-pi the better resistance to chemotherapy drugs, which would be a judgmental marker of prognoses. Under the condition of cell damage stress, antioncoprotein P53 [38] would play central role in maintaining genomic stability by inhibiting the expression of GST-pi which that total radiant efficiency of group micro-down were significantly less than NC-down group (P=0.02861) on the last day. were closely associated with antitumor drug resistance and metastasis. In this study, western blotting was used to detect microRNA-21 overexpression and inhibition in uveal melanoma cell lines, OCM-1, M619 and MuM2B. The results showed that the protein level of LASP1 and GST-pi were up-regulated in micro up groups and down-regulated in micro down groups. According to studies which were mentioned before, the up-regulated LASP1 and GST-pi could be the reason for proliferation and metastasis of tumor. This idea was verified by the results of detection of LASP1 and GST-pi mRNA with qRT-PCR in levius infected uveal melanoma cell lines. LASP1 in microRNA-21 overexpression of uveal melanoma cell lines all showed a statistically significant increase, especially in the highly invasive M619 cells while down-regulation of microRNA-21 statistically significant decrease. However, the mRNA express level of GST-pi in OCM-1 cells with overexpression and inhibition of microRNA-21 were upregulated and down-regulated respectively, but showed no significant difference. GST-pi was decreased in microRNA-21 overexpressing MuM-2B, and increased in M619 cells with inhibition of microRNA-21. This result did not match the Western blot results, which might indicate that partial molecular mechanism may be influenced by characteristics of cytotype differentiation which might be different form driving point as a target. Recent studies show that due to the high level of bio-technology research and bioinformatics commonality, microRNAs in tumor differential expression research is full of possibilities. MicroRNA-21 has been extensively studied in colorectal cancer, breast cancer, glioblastoma of the human brain, and digestive system tumors. Because of its population, region and tumor staging, the clinical manifestations of microRNA-21 are clear. It has been reported that microRNA-21 can be identified as a specific biomarker in a given tumor. In a variety of brain tumors, breast cancer and various gastrointestinal tumors in patients with circulating blood microRNA-21 concentrations can be used as predictors of poor prognosis biomarkers [39] [40] [41] [42] ; in colorectal tumors, circulating microRNA-21 is a biomarker with moderate sensitivity and specificity [43] . Other studies point out that microRNA-21 can be used as a diagnostic tool to screen early cancers [44] and can be used as a translational medicine.
microRnA-21 in uveal melanoma
The present study demonstrated that in uveal melanoma the up-regulated microRNA-21 may inhibit the expression of wild type p53 gene, which could inactivate its inhibition on GST-pi and LASP1, and the increased expression of LASP1 might promote the metastasis and invasion of uveal melanoma cells subsequently in vitro. In vivo, inhibition of microRNA-21 reduced tumor growth. These findings provide novel insight into molecular etiology of microRNA-21 in uveal melanoma cell lines, and suggest that microRNA-21 might be a potential candidate for the diagnosis and prognostic factor of human uveal melanoma in future.
